Our natural way towards innovation
in the healthcare sector
Home >
About us
Postbiotica is a new and dynamic biotechnology company, the result of years of research and experimentation by the team led by Prof. Maria Rescigno, one of the most authoritative figures on the study of the microbiota.
With the aim of seeking innovation in nature to make it available to people’s well-being, we at Postbiotica have devised a new fermentation process called PBTech®.
We are committed to making people aware of their microbiota, the invisible organ, by providing the most effective and natural knowledge and tools to manage and nourish it in the best possible way.
Our story
2016
2017
2018
2019
2021
2022
«Postbiotici per il trattamento delle patologie oncologiche»
2023
The production of postbiotics
according to nature
Thanks to our patented PBTech® technology, we are able to carry out the natural fermentation of bacteria and produce postbiotics from different strains, ready for different uses.
We strongly believe in innovation at the service of people and their daily well-being and we work with passion to offer a wide range of safe, natural and effective postbiotic-based products.
The creation of new products, their continuous improvement and the demonstration of their effectiveness go through an investment in research and development which is the foundation of our work.
Biotech Start-up
in Europe 2021
Our Team
Postbiotics is made up of people with a strongly scientific mindset and specialists in the immune response and in the field of the microbiota.
Our work is guided by a vision projected towards the improvement of technology and the discovery of new possible applications of postbiotics.
Katia Valerio
CEO
Degree in economics and business PhD in Business Administration. Chartered Accountant, Registered in the Register of Auditors. Business Consultant, freelance, with long experience in Deloitte Corporate Finance and Deloitte Consulting. Member of administrative bodies of industrial companies.
Giuseppe Penna
Co-Founder and Scientific Advisor
Worked over 25 years in pharmaceutical environments. His scientific expertise is in the field of immunomodulatory mechanisms applied to the treatment of multiple mucosal inflammatory morbidities and cancer immunotherapy.
He has published over 65 peer-reviewed papers and 12 patents.
Prof. Maria Rescigno
Co-founder, CSO
Full Professor of General Pathology and Deputy Rector with responsibility for research (Humanitas University) and Group Leader Unit of Mucosal Immunology and Microbiota (Humanitas Research Hospital). Over 170 in high-impact journals and scientific books.
Francesca Algieri
Development, Quality & Regulatory affairs
Master Degree in Pharmaceutical Biotechnologies at the University of Perugia PhD in Pharmacology at University of Granada. Experience with inflammatory process, including inflammatory bowel disease, host-microbe interaction and functional food supplements more than 20 studies published
Fabio Gabriele
Product Manager
Master Degree in Biology and a Master in Management and Marketing of the Pharma industry. 4 years’ experience in scientific research and 2 years’ experience in the pharmaceutical field.
Nina Tanaskovic
PhD – R&D
Master degree in Experimental Biomedicine at University of Belgrade, Serbia. PhD in Molecular Medicine – Experimental Oncology at University of Milan. More than 6 years of experience in preclinical research in Molecular Oncology, with the particular focus on Transcription biology and Onco-immunology.
Silvia Pimazzoni
R&D, PhD student
Master degree in Biology at University of Florence
PhD student in Molecular and Experimental Medicine at Humanitas University, Milan
More than 2 years of experience in Cell Biology.
Flavio Venturi
Chief Financial Officer
More than 20 years experience in administration, financial and business leadership.
Alessandro Bernardinello
R&D – PhD student
Master’s degree in Medical and Pharmaceutical Biotechnology at the University of Pavia, PhD student in Molecular and Experimental Medicine at Humanitas University. Two years of experience in the analysis of traditional and innovative pharmaceutical formulations.
I nostri partner
